Immune Checkpoint Inhibitor-Associated Myocarditis

Immune checkpoint inhibitors (ICIs) can induce immunity-related adverse events. We demonstrate the clinical use of cardiac magnetic resonance and endomyocardial biopsy in the diagnosis and subsequent monitoring of ICI-associated myocarditis, suggesting the need to establish and evaluate a cardiac mo...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Grigorios Chatzantonis, MD, Georg Evers, MD, Claudia Meier, MD, Michael Bietenbeck, PhD, Anca Florian, MD, Karin Klingel, MD, Annalen Bleckmann, MD, Ali Yilmaz, MD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2020-04-01
Rangatū:	JACC: Case Reports
Ngā marau:	CMR irAE myocarditis pembrolizumab ventricular tachycardia
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2666084920301467
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Immune Checkpoint Inhibitor-Associated Myocarditis

Ngā tūemi rite